TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments March 22, 1985